Back to Jobs
Summit Therapeutics
Legal & HR Just now

Associate Director of Regulatory Affairs

Summit Therapeutics
United StatesUnited States
Full-time
$168,000–$198,000 USD
Mid-Level

Job Description

Key Skills Required

Master these to land this role

Regulatory AffairsHealth AuthorityBiopharmaceuticalFDAClinical Trials

Want to know if you're a match for this job?

Calculate My Match Score

Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on improving quality of life, increasing potential duration of life, and addressing serious unmet medical needs. The company’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and commitment to people.

The Associate Director of Regulatory Affairs will support the day-to-day regulatory activities of assigned projects with an in-depth knowledge and understanding of the regulatory environment. Global regulatory experience is required. These projects include support for preparation and compilation of submissions for regulatory agencies, tasking clinical studies, managing regulatory submission processes and timelines, regulatory tracking tools, archives, and infrastructure.

Role and Responsibilities:

  • Provides regulatory guidance on project teams and key sub-teams at the study level.
  • Assesses, develops, and implements competitive global regulatory strategies for ivonescimab, identifying potential risks and mitigation steps with proposed strategies.
  • Owns regulatory activities at the molecule and study-level, including clinical trial application (CTA) and IND submissions, review and approval of investigator document packages and associated FDA submissions, and manages other day-to-day regulatory activities of the studies independently.
  • Broadly applies regulatory/technical knowledge of government regulations and skills.
  • Presents and informs study teams of regulatory activities at study team meetings, providing interpretation and application of regulatory requirements.
  • Manages and tracks queries and commitments with regulatory agencies, collaborates with subject matter experts to provide written responses to queries, and provides periodic status updates regarding unfulfilled conditions and/or commitments.
  • Key contributor and owns the regulatory content and strategy for BLA or MAA filings.
  • Tracks timelines, is responsible for the regulatory dossier, and manages regulatory queries.
  • Health authority (HA) meetings: Serves as the health authority (HA) liaison with the FDA for meetings. Prepares and leads project teams in planning regulatory meeting requests and meeting packages, coordinates and leads cross-functional regulatory defense preparation meetings, responds to health authority queries, and attends health authority meetings.
  • Ensures consistency, completeness, and adherence to standards for all regulatory submissions in accordance with regulatory requirements.
  • Demonstrates expertise and knowledge of lung cancer and other indications as needed.
  • Oversees labeling meetings as required.
  • Leads processes by which regulatory submissions are reviewed, finalized, and signed off.
  • Manages the track record of regulatory/ethics submissions and approvals across all studies.
  • Manages document archive processes.
  • Provides cross-coverage when other members are on leave and trains new employees as needed.
  • Supports non-program-specific projects, such as department initiatives and training.
  • All other duties as assigned.

How would you rate this job post?

See what other professionals think about this role.

banner
logo

Summit Therapeutics

View Company Profile

Summit Therapeutics (operating at smmttx.com) is a biopharmaceutical oncology company specializing in the discovery, development, and commercialization of innovative cancer treatments. Founded in 2003 and headquartered in Miami, Florida, the company focuses on addressing unmet needs in oncology by advancing targeted therapies designed to improve patient outcomes. Its pipeline includes promising candidates like ivonescimab, which has already treated over 4,000 patients globally across clinical trials. By leveraging cutting-edge biotechnology and precision medicine, Summit Therapeutics develops treatments tailored to specific cancer subtypes, offering physicians and caregivers more effective options. The company’s approach combines rigorous clinical research with a commitment to accelerating drug approvals, ensuring therapies reach patients faster. Backed by a $500 million private placement in 2025—including significant investments from insiders and leading financial partners—Summit Therapeutics continues to expand its operational footprint while driving progress in oncology.

Safety First

  • Never pay for a job application.
  • Do not share sensitive bank info.
  • Verify the client before starting work.
Learn More